Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
DSP-3456 by Sumitomo Pharma for Treatment Resistant Depression: Likelihood of Approval
DSP-3456 is under clinical development by Sumitomo Pharma and currently in Phase I for Treatment Resistant Depression. According to GlobalData,...